China Journal of Oral and Maxillofacial Surgery ›› 2018, Vol. 16 ›› Issue (1): 1-5.doi: 10.19438/j.cjoms.2018.01.001

• Original Articles • Previous Articles     Next Articles

Study on Twist1 promoting epithelial-mesenchymal transition and drug-resistance in tongue squamous cell carcinoma

LIU Mo1, RUAN Yi1, LI Jing-song1, HUANG Hong-zhang2   

  1. 1.Department of Stomatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University. Guangzhou 510120;
    2 Department of Oral and Maxillofacial Surgery, Guanghua School and Research Institute of Stomatology, Sun Yat-sen University.Guangzhou 510055, Guangdong Province, China
  • Received:2017-06-12 Revised:2017-08-29 Online:2018-01-20 Published:2018-02-11

Abstract: PURPOSE: The aim of this study was to investigate the mechanism of Twist1 regulating epithelial-mesenchymal transition (EMT) and cisplatin-resistance in tongue squamous carcinoma cells. METHODS: TSCC CDDP resistant cell line CAL27/CDDP was transfected with Twist1 siRNA. Western blot and immunofluorescence staining were used to detect the expression of E-cadherin and Vimentin; Western blot was used to detect the expression of Twist1 and Slug; Transwell assay and scratch test were used to detect the invasion and migration capabilities; MTT was used to analyze the half maximal inhibitory concentration (IC50) values. One-way ANOVA was used to analyze the results with SPSS 17.0 software package. RESULTS: Twist1 siRNA transfection reversed EMT phenotype of CAL27/CDDP. The expression of E-cadherin was up-regulated and the expression of Vimentin, Twist1 and Slug was down-regulated. The motility was significantly decreased. The IC50 of CAL27/CDDP decreased by 41.75%±5.10%(P<0.01). CONCLUSIONS: Twist1 promotes EMT and CDDP drug-resistance in TSCC.

Key words: Tongue squamous cell carcinoma, Epithelial-mesenchymal transition, Twist1, Drug resistance

CLC Number: